CATHERINE STEINKAMP: Open Payments
NPI 1730771494 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 43 payments from 17 companies in 2025. Trend: 2023 $36 · 2024 $388 · 2025 $970
Food & beverage: $952Education: $19
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $174 |
| Corcept Therapeutics | 8 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| BETA BIONICS, INC. | 3 | $75 |
| Neurocrine BioSciences, Inc. | 2 | $65 |
| Lilly USA, LLC | 4 | $64 |
| CeQur Corporation | 1 | $61 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
Products named: Kerendia, Korlym, JARDIANCE, iLet Bionic Pancreas, CRENESSITY, CeQur Simplicity, MOUNJARO, UNITHROID.
Industry payments across IN — which companies pay providers there.
